According to The Insight Partners market research study titled ‘Interventional Neuroradiology Market – Global Analysis and Forecasts by Product, Disease and End User. The global interventional neuroradiology market is expected to reach US$ 3,254.55 Mn in 2027 from US$ 1,969.39 Mn in 2018. The market is estimated to grow with a CAGR of 5.9% from 2019-2027. The report highlights the trends prevalent in the global interventional neuroradiology market and the factors driving the market along with those that act as deterrents to its growth.
Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003497/
The interventional neuroradiology market by product is segmented into neurovascular embolization & coiling assist devices and accessories. In 2018, the neurovascular embolization & coiling assist devices segment held a largest market share of 72.17% of the interventional neuroradiology market, by product. This segment is also expected to dominate the market in 2027 owing to increase in the number of interventional neurology procedures. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.
Progressive aging population, increasing demand for minimally invasive procedures and rise in the prevalence of the cerebral aneurysm play vital role in the growth of the interventional neuroradiology market. However, the restraints such as high cost of embolization coils and dearth of skilled professionals are likely to impact the growth of the market in the forecast period.
Some of the players operating in interventional neuroradiology market are, Balt Extrusion, Merit Medical Systems, Terumo Corporation, Medtronic, Penumbra, Inc., Stryker, DePuy Synthes, Boston Scientific Corporation, W. L. Gore & Associates, and MicroPort Scientific Corporation among others. The market players have been establishing acquisitions and collaborations in the market, which enables them to hold a strong position in the market. For instance, in November, 2018, Stryker completed the acquisition of K2M Group Holdings, Inc. The acquisition aims to increase the product portfolio of Stryker’s spine and neurotechnology segment. The developments performed by the companies are helping the market to grow in the coming years.
Market Insights
Rise in the Prevalence of the Cerebral Aneurysm to Drive Global Interventional Neuroradiology Market Growth
Neurological diseases are the disorders of the brain, spine and the nerves that connect them. There are more than 600 diseases of the nervous system, such as brain tumors, epilepsy, Parkinson’s disease and stroke as well as less familiar ones such as front temporal dementia. During recent years, the prevalence of neurological disorders have increased significantly.
A cerebral aneurysm (also called an intracranial aneurysm or brain aneurysm) is a bulging, weakened area in the wall of an artery in the brain, resulting in an abnormal widening, ballooning, or bleb. Because there is a weakened spot in the aneurysm wall, there is a risk for rupture (bursting) of the aneurysm. The most common type of cerebral aneurysm is called a saccular, or berry, aneurysm, occurring in 90 percent of cerebral aneurysms. This type of aneurysm looks like a “berry” with a narrow stem. More than one aneurysm may be present. Two other types of cerebral aneurysms are fusiform and dissecting aneurysms. A fusiform aneurysm bulges out on all sides (circumferentially), forming a dilated artery. Fusiform aneurysms are often associated with atherosclerosis.
Currently, the cause of cerebral aneurysms is not clearly understood. However, brain aneurysms are associated with several causative factors, such as smoking, hypertension, and family history. The most common cause of a brain aneurysm is an abnormal degenerative change in the wall of an artery, and the effects of pressure from the pulsations of blood being pumped forward through the arteries in the brain.
The prevalence of cerebral aneurysms has increased tremendously across the globe. Approximately, 30,000 people in the United States suffer from brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. The annual rate of rupture in the United States is found to be around 8 – 10 per 100,000 people. Hence, the rising prevalence of cerebral aneurysms is anticipated to fuel the growth of the market during the forecast period.
Global Interventional Neuroradiology Market – by Product
- Neurovascular Embolization & Coiling Assist Devices
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Accessories
- Microcatheters
- Microguidewires
Global Interventional Neuroradiology Market – by Disease
- Cerebral Aneurysms
- Intra-Cranial Tumors
- Acute Strokes
- Other Diseases
Global Interventional Neuroradiology Market – by End- User
- Hospitals
- Ambulatory Surgical Centers
- Other End Users
Global Interventional Neuroradiology Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPRE00003497/
Contact Information:
Contact Us Contact Person: Sameer Joshi Phone: +1-646-491-9876 Email Id: sales@theinsightpartners.com
Tags:
, Menafn, PR-Wirein, Research Newswire, English
Contact Information:
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com